Skip to main content
. 2023 Feb 9;7(1):pkad004. doi: 10.1093/jncics/pkad004

Table 2.

Associations of smoking with early- and late-CRC risk

Smoking exposure <55 years
≥55 years
P (interaction) c
Cases Controls ORa (95% CI) ORb (95% CI) Cases Controls ORa (95% CI) ORb (95% CI)
No. (%) No. (%) No. (%) No. (%)
Smoking status .40
 Never 277 (38) 391 (50) 1 (Ref) 1 (Ref) 2527 (46) 3141 (52) 1 (Ref) 1 (Ref)
 Former 216 (30) 208 (26) 1.47 (1.15 to 1.88) 1.39 (1.07 to 1.81) 2267 (41) 2333 (38) 1.25 (1.15 to 1.35) 1.24 (1.13 to 1.36)
 Current 231 (32) 188 (24) 1.74 (1.36 to 2.23) 1.57 (1.20 to 2.04) 746 (13) 605 (10) 1.60 (1.41 to 1.81) 1.46 (1.28 to 1.67)
Pack-years .20
 0 277 (38) 391 (50) 1 (Ref) 1 (Ref) 2527 (46) 3141 (52) 1 (Ref) 1 (Ref)
 1-15 242 (33) 237 (30) 1.44 (1.14 to 1.83) 1.39 (1.08 to 1.79) 1444 (26) 1514 (25) 1.22 (1.11 to 1.34) 1.25 (1.13 to 1.38)
 ≥16 205 (29) 159 (20) 1.85 (1.42 to 2.41) 1.61 (1.21 to 2.14) 1569 (28) 1424 (23) 1.43 (1.31 to 1.57) 1.33 (1.20 to 1.48)
Per 10 pack-years 1.22 (1.11 to 1.33) 1.15 (1.05 to 1.27) 1.07 (1.05 to 1.10) 1.05 (1.03 to 1.08)
a

Adjusted for age and sex. CI = confidence interval; NSAIDs = nonsteroidal antiinflammatory drugs; OR = odds ratio; Ref = reference.

b

Additionally adjusted for previous endoscopy, family history of CRC, education, BMI approximately 10 years before diagnosis (cases) or interview (controls), alcohol consumption, NSAID use (including aspirin), physical activity, and diabetes.

c

P interaction between age (<55 or ≥55 years) and smoking exposure in the comprehensively adjusted model (model B).